2nd Jun 2015 from TwitLonger

Elizabeth Kuiper-EFPIA “There is scope for a more flexible approach to pricing and reimbursement at the national level. We believe that due to the differences in healthcare systems and national economic and medical context, discussion about pricing and reimbursement should take place at national level. At EU level there is however scope for improvement about added value: relative efficacy to speed up market access.”

Reply · Report Post